Strata Critical Medical Stock

Strata Critical Medical ROE

Delisted·Aug 28, 2025

Return on Equity (ROE) of Strata Critical Medical (BLDE) as of Aug 22, 2026.

ROE

0.00

Last updated:

In 2026, Strata Critical Medical's return on equity (ROE) was 0.00, a % increase from the 0.00 ROE in the previous year.

Access this data via the Eulerpool API

Strata Critical Medical Stock analysis

What does Strata Critical Medical do? Blade Air Mobility Inc. is a leading provider of mobility solutions specializing in facilitating flight and helicopter transportation. The company was founded in 2014 in New York City and initially focused on using private jets and helicopters to transport customers to various locations in the greater New York and Hamptons areas. While Blade's core business was initially focused on this local market, the company took its global ambitions seriously, particularly in the rapidly evolving aviation industry. In response to the increasing demand for air taxis and growing interest in urban air mobility, Blade expanded its operations in 2019 and introduced a new innovative air travel app. This app utilizes a fleet of connected vertical takeoff and landing electric aircraft and helicopters to provide fast, quiet, and efficient transportation on key routes from the city. Blade has made waves in the air taxi industry and urban mobility world as part of the growing phenomenon of "urban air mobility." A key part of Blade Air Mobility's success is its sophisticated business model, which allows the company to satisfy a large number of customers. The company works with a variety of flight operators and partners to offer its clients the best selection of air travel, flights, and helicopters. Blade's business model is simple and transparent, as the company charges the same price for all available flights and helicopters on its platform. This allows customers to quickly and easily make a choice without worrying about hidden booking costs. In recent years, Blade has expanded its services to nearly all major US cities, including Los Angeles, San Francisco, Chicago, and Miami. By expanding into these metropolitan areas, Blade is able to reach a much larger customer base and establish a significant market position. Blade has also formed several commercial partnerships to expand the reach and accessibility of the company. In 2019, the company formed a partnership with American Airlines, allowing American Airlines customers to book flights between Manhattan airport and JFK. This partnership enabled Blade to reach a larger audience and gain worldwide recognition. In 2020, Blade also initiated an expansion of its business into electric aircraft engines, taking a leadership position in the emerging market for green electric aircraft. The company collaborates with leading providers of electric aircraft propulsion to develop and test cutting-edge technologies. Blade's goal is to create a more environmentally friendly and sustainable future for commercial aviation. Overall, Blade Air Mobility Inc. has played a significant role in establishing new, smarter, and more efficient forms of intra-city mobility systems and modern urban air taxi networks. The company's intelligent and innovative platform has strengthened its presence in the market and positioned it as a leader in modern urban aviation. Blade's future plans and business initiatives make it an interesting and exciting player in the field of corresponding air mobility and electric flight engines. Strata Critical Medical is one of the most popular companies on Eulerpool.

ROE Details

Decoding Strata Critical Medical's Return on Equity (ROE)

Strata Critical Medical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Strata Critical Medical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Strata Critical Medical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Strata Critical Medical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Strata Critical Medical stock

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Strata Critical Medical since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Strata Critical Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Strata Critical Medical

All Key Metrics — Strata Critical Medical